Skip to main content

Table 2 Detection of HCMV DNA and pp65 in different groups of patients

From: Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients

Groups

n. positive patients (samples)

Median HCMV DNA copies/ml (range)

 

HCMV DNA

pp65

 

KT recipients

24 (66)

5 (16)

17,020 (438-1.58 × 106)

BMT/HSCT recipients

8 (44)

4 (12)

2,480 (316-3.1 × 105)

HIV

10 (14)

2 (2)

2,615 (240-2 × 105)

HM

6 (9)

0

1,100 (316-2,7 × 103)

Total

48 (133)

11 (30)

5,841 (240-1.58 × 106)

  1. KT: kidney transplant; BMT/HSCT: bone marrow/stem cell transplant; HIV: patients with advanced human immunodeficiency virus infection; HM: patients with haematological malignancies.
Back to article page